Dr Kostas Dimopoulos is a consultant cardiologist at the Royal Brompton Hospital specialising in adult congenital heart disease (ACHD) and pulmonary hypertension (PH).
Dr Dimopoulos’ research is predominantly clinical, aimed at addressing important unanswered questions in the area of ACHD and PH. He has published over 200 papers in this area and is the editor for a book on pulmonary hypertension in congenital heart disease (Springer 2017), one of the most complex areas in cardiology.
et al., 2020, A single-centre, placebo-controlled, double-blind randomised cross-over study of nebulised iloprost in patients with Eisenmenger syndrome: A pilot study, International Journal of Cardiology, Vol:299, ISSN:0167-5273, Pages:131-135
et al., 2020, Non-vitamin K antagonist oral anticoagulants (NOACs) for thromboembolic prevention, are they safe in congenital heart disease? Results of a worldwide study, International Journal of Cardiology, Vol:299, ISSN:0167-5273, Pages:123-130
et al., Sex differences in hypertrophic cardiomyopathy: time to tailor risk stratification and therapy?, European Journal of Preventive Cardiology, ISSN:2047-4873
et al., 2019, Management of Adults with Congenital Heart Disease and Pulmonary Arterial Hypertension in the UK: Survey of Current Practice, Unmet Needs and Expert Commentary (vol 27, pg 1018, 2018), Heart Lung and Circulation, Vol:28, ISSN:1443-9506, Pages:1915-1915
et al., 2019, Early and late effects of cardiac resynchronization therapy in adult congenital heart disease, Journal of the American Heart Association, Vol:8, ISSN:2047-9980